Intramuscular pentazocine versus Intramuscular acetaminophen for pain relief during labour in federal medical centre, Abuja: A randomized controlled study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202307474015398

Enrollment

202

Registered

2023-07-10

Start date

2023-07-03

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labour Analgesia

Interventions

Intramuscular Acetaminophen

Intramuscular pentazocine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Pregnant women, 2.Gestational age between 37 and 42 weeks, 3. Singleton fetus, 4. Active phase of labour, 5.Cervical dilation of 4-6 cm, 6.Consented to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Non-consenting pregnant women, 2. Allergy to pentazocine and acetaminophen, 3. Intrauterine fetal death, 4. Fetal distress, 5. Antepartum hemorrhage 6. Chronic or recent liver disease, renal disease, 7. Diabetes mellitus, 8. Cardiopulmonary depression, 9. Multiple gestation 10. Patient with previous Caeserean section 11. Patient with induced labour and augmentation 12. IVF conception.

Design outcomes

Primary

Measure	Time frame
Significant reduction in the intensity of labour pain after administration of analgesic agents.	—

Secondary

Measure	Time frame
a. Maternal satisfaction with the analgesia b. Side effects associated with pain relief. c. Fetal outcome among the two groups of women who had intramuscular pentazocine and intramuscular acetaminophen in labour.	—

Countries

Nigeria

Contacts

Public ContactJuliet Ucha

consultant with npmcn

diutonwa@gmail.com+23408035397945

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026